{"id":1612,"date":"2004-12-01T12:03:00","date_gmt":"2004-12-01T11:03:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2004\/moegliche-uaw-von-travoprost-augentropfen-isotretinoin-und-candesartan"},"modified":"2004-12-01T12:03:00","modified_gmt":"2004-12-01T11:03:00","slug":"moegliche-uaw-von-travoprost-augentropfen-isotretinoin-und-candesartan","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2004\/moegliche-uaw-von-travoprost-augentropfen-isotretinoin-und-candesartan","title":{"rendered":"M\u00f6gliche UAW von Travoprost-Augentropfen, Isotretinoin und Candesartan"},"content":{"rendered":"<p>Im British Medical Journal wird immer wieder unter der Rubrik \u201eDrug points\u201d \u00fcber neue UAW berichtet. M. Kumarasamy und S.P. Desai aus England (1) berichten \u00fcber eine 77-j\u00e4hrige Frau, die wegen eines pseudoexfoliativen Glaukoms bei beidseitigem Grauem Star zweimal nach Verabreichung von Travoprost-Augentropfen (in Deutschland Travatan 40\u00ae) eine schwere anteriore Uveitis mit Hornhaut\u00f6dem und Iritis [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Im British Medical Journal wird immer wieder unter der Rubrik \u201eDrug points\u201d \u00fcber neue UAW berichtet. M. Kumarasamy und S.P. Desai aus England (1) berichten \u00fcber eine 77-j\u00e4hrige Frau, die wegen eines pseudoexfoliativen Glaukoms bei beidseitigem Grauem Star zweimal nach Verabreichung von Travoprost-Augentropfen (in Deutschland Travatan 40\u00ae) eine schwere anteriore Uveitis mit Hornhaut\u00f6dem und Iritis [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[316,309,312,314,313,315,317,320,311,307,319,310,1226,151,3754,642,306,3753,3752],"class_list":["post-1612","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-angiotensin-ii-antagonisten","tag-angiotensin-ii-blocker","tag-angiotensin-ii-inhibitoren","tag-angiotensin-ii-rezeptor-antagonisten","tag-angiotensin-ii-rezeptor-blocker","tag-angiotensin-ii-rezeptor-inhibitoren","tag-at-ii-antagonisten","tag-at-ii-blocker","tag-at-ii-inhibitoren","tag-at-ii-rezeptor-antagonisten","tag-at-ii-rezeptor-blocker","tag-at-ii-rezeptor-inhibitoren","tag-candesartan","tag-guillain-barre-syndrom","tag-hypersensitivitaetssyndrom","tag-isotretinoin","tag-sartane","tag-travoprost","tag-uveitis"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1612","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1612"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1612\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1612"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1612"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}